| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Futura Medical erhält EU-Zulassung für Eroxon Intense Gel | 1 | Investing.com Deutsch | ||
| Fr | Futura Medical receives EU clearance for Eroxon Intense gel | 1 | Investing.com | ||
| Fr | Futura Medical PLC - EU Market Launch Clearance | - | RNS | ||
| 20.07. | AIM Market Roundup: Sunrise Resources, Futura Medical, Plexus | 3 | The Armchair Trader | ||
| 08.07. | IN BRIEF: Futura Medical disputes European Union patent revocation | 7 | Alliance News | ||
| 07.07. | Futura Medical's European patent for Eroxon revoked | 4 | Investing.com | ||
| 07.07. | Futura Medical PLC - MED3000 (Eroxon) European Patent Opposition | 1 | RNS | ||
| 30.06. | Futura Medical PLC - Holding(s) in Company | - | RNS | ||
| FUTURA MEDICAL Aktie jetzt für 0€ handeln | |||||
| 30.06. | Futura Medical PLC - Highly positive data from WSD4000 studies | 2 | RNS | ||
| 29.06. | Futura Medical PLC - Correction: Result of AGM | - | RNS | ||
| 29.06. | Futura Medical PLC - Result of AGM | - | RNS | ||
| 29.06. | Futura Medical teams up with MPG for Eroxon as ends Haleon agreement | 7 | Alliance News | ||
| 29.06. | Futura Medical PLC - New US commercial partner | - | RNS | ||
| 04.06. | Futura Medical PLC - Notice of AGM & availability of Annual Report | 5 | RNS | ||
| 22.05. | Futura Medical PLC - Holding(s) in Company | 3 | RNS | ||
| 29.04. | Futura Medical PLC - Unaudited Results for the Year Ended 31 Dec 2025 | 10 | RNS | ||
| 20.04. | Futura Medical PLC - Notice of Results & Investor Presentation | 4 | RNS | ||
| 23.03. | Futura Medical "very pleased" by Eroxon testing results | 17 | Alliance News | ||
| 23.03. | AIM Market Roundup: Quadrise, Iomart, Futura Medical | 3 | The Armchair Trader | ||
| 23.03. | Futura Medical reports positive trial results for Eroxon products | 1 | Investing.com |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NOVO NORDISK | 40,900 | -7,36 % | Novo Nordisk und Eli Lilly zeigen, wie Blockbuster entstehen - warum Biotech-Unternehmen mit Produkten plötzlich anders bewertet werden | ||
| GILEAD SCIENCES | 113,32 | +0,35 % | Cantor Fitzgerald reiterates Gilead Sciences stock rating at Overweight | ||
| AURORA CANNABIS | 2,422 | +0,25 % | Aurora Cannabis Inc (3): Aurora gets ISS backing ahead of annual meeting vote | ||
| CANOPY GROWTH | 0,790 | -0,65 % | Drama um Canopy, Tilray & Co?: Anhörungsprozess zu Cannabis endet - Stürzt die DEA den Sektor ins Chaos? | © Foto: adobe.stock.comAm 29. Juni begann der Anhörungsprozess der DEA zur möglichen Neueinstufung von Freizeit-Cannabis in Schedule III. Mittlerweile steht der Anhörungsprozess vor seinem Ende. Was... ► Artikel lesen | |
| TILRAY BRANDS | 3,915 | -0,89 % | Tilray Brands dreht auf - doch dieser Haken bleibt | ||
| VERTEX PHARMACEUTICALS | 413,25 | -0,10 % | Vertex Just Paid $10 Billion for Crinetics. Here's Why Viking Therapeutics Could Be the Next Big Pharma Takeover Target | ||
| INNOCAN PHARMA | 1,690 | -2,59 % | Innocan Pharma Corporation: Valitic Surpasses 2 Million Trusted Customers, Marking a Major Milestone in Its Consumer Wellness Growth | The rapidly growing skincare brand continues to strengthen its position in the U.S. beauty market through innovation, quality, and customer trust.HERZLIYA, Israel and CALGARY, AB, July 29... ► Artikel lesen | |
| BIOTEST | 33,200 | +0,61 % | Osborne Clarke berät Grifols S.A. bei der Umwandlung der Biotest AG in eine GmbH & Co. KGaA | ||
| CRONOS GROUP | 2,484 | +1,06 % | Cronos Group Inc. Announces Results of 2026 Annual Meeting of Shareholders | TORONTO, June 22, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company") today announced that at its Annual Meeting of Shareholders held on Thursday, June... ► Artikel lesen | |
| SYNBIOTIC | 1,012 | -5,77 % | EQS-Adhoc: SYNBIOTIC SE: SOLIDMIND Group GmbH und Lean Labs Pharma GmbH beabsichtigen, Anträge auf Eröffnung von Insolvenzverfahren zu stellen | EQS-Ad-hoc: SYNBIOTIC SE / Schlagwort(e): Strategische Unternehmensentscheidung/Insolvenz
SYNBIOTIC SE: SOLIDMIND Group GmbH und Lean Labs Pharma GmbH beabsichtigen, Anträge auf Eröffnung... ► Artikel lesen | |
| DIGICANN VENTURES | 0,003 | 0,00 % | XFRA VY3: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| EYEPOINT | 10,500 | 0,00 % | EyePoint, Inc.: EyePoint Completes Enrollment of Both Pivotal Phase 3 Trials of DURAVYU for Treatment of Diabetic Macular Edema (DME) | - COMO and CAPRI trials together rapidly enrolled over 480 participants in five months, demonstrating continued enthusiasm for DURAVYU trial participation among retinal specialists and patients --... ► Artikel lesen | |
| EDWARDS LIFESCIENCES | 74,46 | -0,21 % | Is the Options Market Predicting a Spike in Edwards Lifesciences Stock? | ||
| ORGANIGRAM GLOBAL | 0,843 | +3,56 % | Organigram Global Inc.: Organigram Closes Previously Announced Acquisition of Sanity Group, Private Placement Financing with BAT and ATB Senior Secured Credit Facilities | Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram") and Sanity Group GmbH ("Sanity" or "Sanity Group") jointly announced the successful closing of Organigram's previously... ► Artikel lesen | |
| GREEN THUMB INDUSTRIES | 6,060 | -1,62 % | Green Thumb Industries Inc: Green Thumb to open dispensary in Pennsylvania |